(S) -Navlimetostat
(S) -Navlimetostat (example 16-7) is the S-enantiomer of Navlimetostat. (S) -Navlimetostat is a PRMT5/MTA complex inhibitor, with an IC50 of 7070 nM[1].
Product Specifications
CAS Number
[2630904-44-6]
Product Name Alternative
(S) -MRTX-1719; (S) -BMS-986504
UNSPSC
12352005
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/s-mrtx-1719.html
Purity
95.15
Solubility
10 mM in DMSO
Smiles
FC1=C(C=C(C(C#N)=[C@@]1[C@@]2=C(C3=CC=C4C(C(CN)=NNC4=O)=C3)C=NN2C)OC5CC5)Cl
Molecular Formula
C23H18ClFN6O2
Molecular Weight
464.88
References & Citations
[1]Thomas P. BOBINSKI, et al. Mta-cooperative prmt5 inhibitors. WO2021050915A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PRMT5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
130331-ML550 100 µL
NFIA (KIAA1439, Nuclear Factor 1 A-type, CCAAT-box-binding Transcription Factor, Nuclear Factor I/A, TGGCA-binding Protein) (MaxLight 550)
Ask
View Details 
MBS6160521-01 0.1 mL
STAC (SH3 and Cysteine-rich Domain-containing Protein, Src Homology 3 and Cysteine-rich Domain-containing Protein, FLJ32331) (PE)
Ask
View Details 
MBS6160521-02 5x 0.1 mL
STAC (SH3 and Cysteine-rich Domain-containing Protein, Src Homology 3 and Cysteine-rich Domain-containing Protein, FLJ32331) (PE)
Ask
View Details